Fatal hyponatremia in a young woman after ecstasy ingestion

Nature Clinical Practice Nephrology

Volumn 2, Issue 5, 2006, Pages 283-288

  Kalantar Zadeh, Kamyar ^a,b,c,e   Nguyen, Minhtri K ^a,b,c   Chang, Roger ^a,b,c,d   Kurtz, Ira ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Division of Nephrology and Hypertension   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST JOSEPH HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ecstasy; Estrogen; Hyponatremic encephalopathy; MDMA; Noncardiogenic pulmonary edema

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ELECTROLYTE; FUROSEMIDE; MANNITOL; SODIUM; SODIUM CHLORIDE;

ADULT; ARTERIAL GAS; ARTICLE; BLOOD CHEMISTRY; BRAIN EDEMA; CASE REPORT; COLLEGE STUDENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; LABORATORY TEST; NONCARDIOGENIC LUNG EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SODIUM BLOOD LEVEL; THORAX RADIOGRAPHY; URINALYSIS; URINE OSMOLALITY;

ADULT; FATAL OUTCOME; FEMALE; HALLUCINOGENS; HUMANS; HYPONATREMIA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 33646859246     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0167     Document Type: Article

References (18)

1. Ayus JC and Arieff AI (1995) Pulmonary complications of hyponatremic encephalopathy: noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest 107: 517-521
2. Ayus JC and Arieff AI (1999) Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA 281: 2299-2304
3. Gowing LR et al. (2002) The health effects of ecstasy: a literature review. Drug Alcohol Rev 21: 53-63
4. Cherney DZ et al. (2002) Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis. QJM 95: 475-483
5. Brvar M et al. (2004) Polydipsia as another mechanism of hyponatremia after 'ecstasy' (3,4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med 11: 302-304
6. Fallon JK et al. (2002) Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann NY Acad Sci 965: 399-409
7. Haldane JS and Priestley JG (1916) The regulation of excretion of water by the kidneys. J Physiol London 50: 296-303
8. Budisavljevic MN et al. (2003) Hyponatremia associated with 3,4-methylenedioxymethyl amphetamine ("Ecstasy") abuse. Am J Med Sci 326: 89-93
9. Hartung TK et al. (2002) Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion. QJM 95: 431-437
10. Balmelli C et al. (2001) Fatal brain edema after ingestion of ecstasy and benzylpiperazine. Dtsch Med Wochenschr 126: 809-811
11. Parr MJ et al. (1997) Hyponatraemia and death after "ecstasy" ingestion. Med J Aust 166: 136-137
12. O'Connor A et al. (1999) Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use. NZ Med J 112: 255-256
13. Ayus JC et al. (2000) Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med 132: 711-714
14. Arieff AI and Ayus JC (1993) Endometrial ablation complicated by fatal hyponatremic encephalopathy. JAMA 270: 1230-1232
15. Arieff AI et al. (1995) Age, gender, and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy. Am J Physiol 268: R1143-R1152
16. Ayus JC et al. (1992) Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 117: 891-897
17. Kurtz I and Nguyen MK (2003) A simple quantitative approach to analyzing the generation of the dysnatremias. Clin Exp Nephrol 7: 138-143
18. Nguyen MK and Kurtz I (2004) New insights into the pathophysiology of the dysnatremias: a quantitative analysis. Am J Physiol Renal Physiol 287: F172-F180